- Home
- TMO
as 10-07-2025 3:28pm EST
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
| Founded: | 1956 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 175.3B | IPO Year: | N/A |
| Target Price: | $584.79 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 17.30 | EPS Growth: | 7.24 |
| 52 Week Low/High: | $385.46 - $610.97 | Next Earning Date: | 10-22-2025 |
| Revenue: | $43,212,000,000 | Revenue Growth: | 2.04% |
| Revenue Growth (this year): | 3.54% | Revenue Growth (next year): | 4.83% |
Stock Insider Trading Activity of Thermo Fisher Scientific Inc (TMO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CASPER MARC N | TMO | Chairman & CEO | Sep 5 '25 | Sell | $500.67 | 400 | $200,201.00 | 113,762.285 | |
| Holmes Joseph R. | TMO | VP & Chief Accounting Officer | Aug 29 '25 | Sell | $492.62 | 385 | $189,661.91 | 2,603.982 | |
| CASPER MARC N | TMO | Chairman & CEO | Aug 22 '25 | Sell | $501.44 | 10,000 | $5,009,586.03 | 113,762.285 | |
| CASPER MARC N | TMO | Chairman & CEO | Aug 20 '25 | Sell | $500.07 | 295 | $147,512.35 | 113,762.285 | |
| CASPER MARC N | TMO | Chairman & CEO | Aug 19 '25 | Sell | $500.17 | 201 | $100,533.59 | 113,762.285 |
Latest Thermo Fisher Scientific Inc News
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
StockStory
21 hours ago
3 Unpopular Stocks That Fall Short
Insider Monkey
a day ago
Jim Cramer Wonders If He Gave Up On Danaher (DHR) “At The Bottom”
Insider Monkey
3 days ago
Jim Cramer on Thermo Fisher: “They Really Got Hurt By COVID”
StockStory
4 days ago
Why Thermo Fisher (TMO) Stock Is Trading Up Today
Insider Monkey
5 days ago
Where is Thermo Fisher Scientific (TMO) Headed According to Analysts?
Simply Wall St.
5 days ago
Can Thermo Fisher (TMO) Balance Biomanufacturing Expansion and AI Ambitions to Shape Its Long-Term Edge?
MT Newswires
6 days ago
Barclays Adjusts Price Target on Thermo Fisher Scientific to $585 From $550, Maintains Overweight Rating
Zacks
6 days ago
Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker
Compare TMO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.